News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Fibrocell Science, Inc. Announces Second Quarter 2012 LAVIV Order Information


7/17/2012 10:06:39 AM

EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc. (OTCBB: FCSC), announced today its LAVIV order information for the second quarter ended June 30, 2012. During the second quarter of 2012, Fibrocell received orders for 387 biopsies, an increase of 104% as compared to 189 orders during the first quarter of 2012. During the second quarter of 2012, 85 new physicians placed orders for biopsies, an increase of 60% as compared to 53 new physicians during the first quarter of 2012. During the second quarter of 2012, 39 physicians placed repeat orders for biopsies, an increase of 200% as compared to 13 physicians during the first quarter of 2012. Since the launch of LAVIV in June 2011, Fibrocell has received 706 biopsy orders from 162 physicians.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES